Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide vs Clobetasol for MTX-induced Oral Ulcers
NCT04649697Phase 3Unknown
- Sponsor
- Cairo University
- Start
- Dec 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rebamipide in oral mucositis (OM), sponsored by Cairo University. Status: unknown.
02
Drugs
rebamipide
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT04649697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04649697.